Duration and impact of adverse events with esketamine nasal spray and quetiapine extended release in the ESCAPE-TRD phase IIIb trial

E Vieta, P.M Llorca + Show 7 more

Open Access

https://doi.org/10.1016/j.nsa.2023.102949

Copy DOI

Journal: Neuroscience Applied	Publication Date: Jan 1, 2023
License type: cc-by-nc-nd

Abstract

Duration and impact of adverse events with esketamine nasal spray and quetiapine extended release in the ESCAPE-TRD phase IIIb trial

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author